ANA LLUCH HERNANDEZ-rekin lankidetzan egindako argitalpenak (5)

2009

  1. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

    Cancer Research, Vol. 69, Núm. 10, pp. 4116-4124

  2. Guidelines for HER2 testing in breast cancer. A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    Revista Espanola de Patologia, Vol. 42, Núm. 1, pp. 3-16

  3. Guidelines for HER2 testing in breast cancer: A national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM)

    Clinical and Translational Oncology, Vol. 11, Núm. 6, pp. 363-375

2006

  1. Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor

    Annals of Oncology, Vol. 17, Núm. 11, pp. 1644-1649

2001

  1. Heterogeneous lack of expression of the tumour suppressor PTEN protein in human neoplastic tissues

    European Journal of Cancer, Vol. 37, Núm. 1, pp. 114-121